Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma
Increasing evidence supports a potential role for STAT3 as a tumor driver in cutaneous T-cell lymphomas (CTCL). The mechanisms leading to STAT3 activation are not fully understood; however, we recently found that miR-124, a known STAT3 regulator, is robustly silenced in MF tumor-stage and CTCL cells...
Main Authors: | Lidia García-Colmenero, Jéssica González, Juan Sandoval, Yolanda Guillén, Angel Diaz-Lagares, Evelyn Andrades, Arnau Iglesias, Lara Nonell, Ramon Maria Pujol, Anna Bigas, Lluís Espinosa, Fernando Gallardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/12/2692 |
Similar Items
-
Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?
by: Małgorzata Gałecka, et al.
Published: (2022-04-01) -
The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms
by: Jia Liu, et al.
Published: (2023-01-01) -
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
by: Inés Roger, et al.
Published: (2021-05-01) -
Editorial: JAK inhibition in autoimmune and inflammatory diseases
by: Jean-Baptiste Telliez, et al.
Published: (2022-12-01) -
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
by: Emira Bousoik, et al.
Published: (2018-07-01)